Benzinga··Globe NewswireLifeMD Declares Quarterly Dividend on Preferred Stock Series A
LifeMD announces $0.5546875 quarterly dividend per share on Series A Cumulative Perpetual Preferred Stock, payable April 15, 2026.
LFMDLFMDPdividendtelemedicine
telemedicine
7 articlesBenzinga··Globe Newswire
GlobeNewswire Inc.··Mangoceuticals, Inc.Mangoceuticals Sues Clarity Ventures for $73M Over Failed Platform Delivery
Mangoceuticals sues former vendor Clarity Ventures for $73M over failed ERP platform delivery. Company developed proprietary telehealth solution independently.
MGRXtelemedicinelawsuit
The Motley Fool··Geoffrey SeilerHims & Hers Surges 40% on Novo Nordisk Deal, But Valuation Concerns Linger
Hims & Hers surges 40% after Novo Nordisk partnership resolves litigation, enabling authorized distribution of Wegovy and Ozempic. Stock trades under 20x forward P/E.
NVOHIMSGLP-1 drugstelemedicine
GlobeNewswire Inc.··Researchandmarkets.ComRespiratory Testing Market Set to Surge 56% by 2032 as Diagnostics Innovation Accelerates
Global respiratory testing market projected to reach $9.32B by 2032, growing 6.50% annually from $5.99B in 2025, driven by molecular diagnostics and telemedicine innovations.
MDTABTRHHBYTMOPHG+3strategic partnershipssupply chain resilience
The Motley Fool··Rich SmithHims & Hers Faces Growth Deceleration as GLP-1 Market Dynamics Shift
Hims & Hers stock plunged 70% as GLP-1 market competition intensifies and growth slows. Despite challenges, company projects $2.8B 2026 revenue from diversified services.
LLYNVOHIMSearnings reportGLP-1 drugs
The Motley Fool··Prosper Junior BakinyTeladoc Faces Structural Challenges as Telemedicine Market Matures
Teladoc's stock plummeted 98% as telemedicine demand normalized post-pandemic. The company faces structural challenges, slower growth, profitability issues, and intensifying competition from larger healthcare providers.
AMZNTDOCstock declinecompetition
GlobeNewswire Inc.··NaTalkspace Posts 22% Revenue Growth in 2025 on Strong Payor Segment Gains
Talkspace reported 22% revenue growth in 2025, reaching $228.9M, driven by strong enterprise payor gains despite consumer-direct declines. Turned profitable with $7.8M net income.
TALKTALKWprofitabilityrevenue growth